Richard A. Heyman

Director

Director at Enliven Therapeutics, Inc., filing insider transactions on 2026-02-17.

Total Purchases

—

0 transactions

Total Sales

$32K

1 transaction

Companies Traded

1

1 total filings

Active Since

2026-02-17

Last: 2026-02-17

Companies

Enliven Therapeutics, Inc.

Other Reporting Insiders at Enliven Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-17	ELVN	Sale	1,230	$26.18	$32K	22.6K	SEC ↗

Richard A. Heyman (Enliven Therapeutics, Inc.) Insider Trades | Tormere